1. Global, Regional, and National Burden of Myocarditis From 1990 to 2017: A Systematic Analysis Based on the Global Burden of Disease Study 2017;Wang;Front Cardiovasc Med,2021
2. Myocarditis With COVID-19 mRNA Vaccines;Bozkurt;Circulation,2021
3. SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents;Karlstad;JAMA Cardiol,2022
4. EMA/PRAC/683817/2021. Signal assessment report on Myocarditis, pericarditis with Tozinameran (COVID-19 mRNA vaccine (nucleoside modified) – COMIRNATY) 2021 [Available from: https://www.ema.europa.eu/en/documents/prac-recommendation/signal-assessment-report-myocarditis-pericarditis-tozinameran-covid-19-mrna-vaccine_en.pdf.
5. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review;Pillay;BMJ (Clinical research ed),2022